The phosphorylation levels of AMPK at Thr172 and LKB1 at Ser428 were significantly increased by RGZ treatment (Figure 4), suggesting that the Sirt6-AMPK pathway may be involved in the beneficial effects of RGZ on hepatic steatosis. Here, SIRT6 is linked to fatty liver disease.